Name: SPRY Balance Sheet - Ars Pharmaceuticals Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

SPRY - Ars Pharmaceuticals, Inc.

USD | NASDAQ | Healthcare

SPRY Balance Sheet - Ars Pharmaceuticals Assets & Debt | Ledgeburg

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19
Cash And Short Term Investments
Cash And Equivalents	24.3	41.3	59.6	51.5	39.9	50.8	39.7	36.6	56.0	71.0	60.5	119.0	87.9	210.5	203.2

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Cash And Short Term Investments
Cash And Equivalents	41.3	50.8	71.0	210.5	60.1	386.6	-
Restricted Cash	-	-	-	-	-	-	-
Short Term Investments	203.7	263.2	157.4	63.9	0.0	-	-
Cash And Short Term Investments	245.0	314.0	228.4	274.4	60.1	386.6	-
Receivables
Accounts Receivable	25.3	8.2	0.0	-	-	-	-
Current Assets
Inventory	31.4	10.5	0.0	-	-	-	-
Prepaid Expenses	6.2	6.9	3.4	3.3	0.7	4.1	-
Non-Current Assets
Property, Plant & Equipment Gross	-	-	0.7	0.4	0.1	3.7	-
Accumulated Depreciation	-	0.2	0.1	0.0	0.0	2.1
Current Liabilities
Accounts Payable	5.7	9.9	0.8	1.7	1.8	2.6	-
Short Term Debt	-	-	-	-	-	-	-
Non-Current Liabilities
Long Term Debt	96.4	0.0	-	-	-	-	-
Operating Lease Liabilities Non-Current	-	0.0	0.0	0.3	0.5	2.3
Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	-
Additional Paid In Capital	408.7	379.9	362.0	349.4	11.0	479.6
Supplementary Data
Total Debt	96.4	0.0	-	-	-	-	-
Net debt	(148.6)	(314.0)	-	-	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Assets
Inventory	32.0	31.4	21.4	22.1	7.3	10.5	0.7	-	-	0.0	0.0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	6.8	6.2	6.4	7.4	11.6	6.9	2.7	2.0	2.6	3.4	2.6	2.8	2.8	3.3	4.2	5.2	7.5	7.4
Other Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	245.2	284.9	338.9	281.4	303.9	334.3	208.8	220.7	226.2	231.7	244.5	255.0	267.4	277.7	270.8	263.1

Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-	-	0.7	0.7	0.7	0.7	0.7	0.4	-	-	-	-	-	-	-	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-	-	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.0	-	-	-
Property,Plant & Equipment Net	2.3	2.5	1.2	1.1	1.1	1.0	0.8	0.6	0.6	0.6	0.6	0.6	0.6	0.3	0.0	2.5	2.4
Long Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.0	24.2	44.0
Equity Method Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible Assets	14.2	14.5	14.7	13.0	7.2	7.4	7.5	-	-	0.0	-	-	-	-	-	-	-	-
Operating Lease Right Of Use Assets	-	-	1.4	1.6	0.1	0.0	0.1	0.1	0.2	0.3	0.3	0.3	0.4	0.4	0.0	3.9
Deferred Tax Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Assets	-	-	-	-	-	-	-	-	-	-	0.7	0.1	-	0.0	-	-	-
Total Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	287.6	327.7	372.8	313.5	327.3	351.2	217.6	222.0	227.6	233.2	248.6	258.8	271.2	281.4	271.1	294.0	312.5

Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-	-	-
Additional Paid In Capital	416.6	408.7	400.9	394.5	386.1	379.9	373.9	369.5	365.6	362.0	361.6	358.0	353.0	349.4	516.8	510.6	505.3
Retained Earnings	(355.2)	(294.6)	(253.3)	(202.1)	(157.2)	(123.3)	(173.2)	(154.1)	(141.6)	(131.3)	(124.1)	(109.3)	(91.9)	(76.9)	(248.1)	(230.3)	(210.8)
Accumulated Other Comprehensive Income	(0.1)	0.1	(0.0)	(0.0)	0.1	0.2	0.3	(0.1)	(0.1)	0.0	(0.2)	(0.2)	0.1	0.4	(1.6)	(1.5)
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	61.3	114.3	147.7	192.3	229.0	256.8	201.0	215.2	223.9	230.8	237.3	248.6	261.2	272.9	(50.2)	(44.0)	(38.3)
Total Equity	61.3	114.3	147.7	192.3	229.0	256.8	201.0	215.2	223.9	230.8	237.3	248.6	261.2	272.9	(50.2)	(44.0)	(38.3)	(31.3)

Supplementary Data
Total Debt	96.5	96.4	96.2	-	-	0.0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net debt	(104.4)	(148.6)	(192.0)	-	-	(314.0)	-	-	-	-	-	-	-	-	-	-	-	-	-
Working Capital	195.6	245.8	288.0	235.8	276.2	310.9	192.2	214.0	222.5	229.3	233.3	245.0	257.5	272.3	266.8	252.0	246.5	246.6
Book Value	61.3	114.3	147.7	192.3	229.0	256.8	201.0	215.2	223.9	230.8	237.3	248.6	261.2	272.9	(50.2)	(44.0)	(38.3)	(31.3)
Tangible Book Value	47.1	99.8	132.9	179.3	221.7	249.4	193.5	-	-	230.8	-	-	-	-	-	-	-

Receivables
Accounts Receivable	28.7	25.3	36.5	25.1	9.3	8.2	0.8	-	-	0.0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Current Liabilities
Accounts Payable	4.7	5.7	8.4	15.6	4.1	9.9	8.3	3.3	0.8	0.8	3.0	1.5	2.6	1.7	0.1	2.1	2.6	2.1	1.7	1.8	4.4	2.6	-	-	-	-
Short Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	0.8	0.6	0.5	0.7	0.5	0.6	-	-	-	-	0.0	0.0	0.0	0.3	-	-	-
Operating Lease Liabilities Current	-	-	0.6	0.6	0.1	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.9
Accrued Expenses	-	-	5.4	4.3	-	2.3	-	-	-	-	-	-	-	-	3.6	8.1	11.1	11.7
Other Current Liabilities	0.6	0.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	49.6	39.1	50.9	45.6	27.6	23.4	16.6	6.7	3.7	2.4	11.2	10.1	9.8	5.4	4.0	11.1